The treatment targets a host of diseases during the early season, including Phytophthora, Rhizoctonia, Pythium, Fusarium, seedborne Phomopsis and seedborne Sclerotinia.
The active ingredients are mefenoxam, fludioxonil and sedaxane.
“The higher rate of mefenoxam in Vibrance Trio offers the highest level of Phytophthora and Pythium protection available,” Steve Gomme, Seedcare product lead at Syngenta, said in a news release. “This helps give growers confidence when they desire early planting in unpredictable conditions, establishing stronger soybean stands and reducing the risk of replants.”
In trials conducted between 2015 and 2017 across 31 different field environments, the early season disease protection of Vibrance Trio resulted in a higher stand count 87 percent of the time compared to the check. Those trials were conducted in Oklahoma, Iowa, Georgia, Ohio, Alabama, Arkansas, Louisiana, North Carolina, Indiana Tennessee, Texas and Mississippi.
Additionally, in trials conducted during 2011 and 2012 in Nebraska, Wisconsin, Missouri, Iowa, Minnesota, Illinois, Indiana and Ohio, Vibrance Trio increased yield by an average of 2.2 bushels per acre compared to the industry standard in heavy disease environments.